[HTML][HTML] Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside

EJ Rahn, AG Hohmann - Neurotherapeutics, 2009 - Elsevier
Neuropathic pain is a debilitating form of chronic pain resulting from nerve injury, disease
states, or toxic insults. Neuropathic pain is often refractory to conventional …

Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists

S Han, J Thatte, DJ Buzard… - Journal of medicinal …, 2013 - ACS Publications
The cannabinoid receptor type 2 (CB2) is a class A GPCR that was cloned in 1993 while
looking for an alternative receptor that could explain the pharmacological properties of Δ9 …

Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists

MH Deventer, K Van Uytfanghe… - Drug Testing and …, 2022 - Wiley Online Library
In recent years, several nations have implemented various measures to control the surge of
new synthetic cannabinoid receptor agonists (SCRAs) entering the recreational drug market …

Synthesis and properties of hydrazones bearing amide, thioamide and amidine functions

NP Belskaya, W Dehaen, VA Bakulev - 2010 - elar.urfu.ru
This review provides detailed methods for the synthesis, structures and chemical properties
of hydrazones bearing carboxamide, thioamide and amidine functions. The main accent was …

Identification of AD‐18, 5F‐MDA‐19, and pentyl MDA‐19 in seized materials after the class‐wide ban of synthetic cannabinoids in China

CM Liu, ZD Hua, W Jia, T Li - Drug Testing and Analysis, 2022 - Wiley Online Library
To curb the manufacturing, trafficking, and abuse of synthetic cannabinoids, China
implemented a class‐wide regulation on synthetic cannabinoids in July 2021. Recently …

EMCDDA framework and practical guidance for naming synthetic cannabinoids

B Pulver, S Fischmann, A Gallegos… - Drug Testing and …, 2023 - Wiley Online Library
Synthetic cannabinoids (SCs), often sold as “legal” replacements for cannabis, are the
largest group of new psychoactive substances monitored by the European Monitoring …

Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives

YO Teng, HY Zhao, J Wang, H Liu, ML Gao… - European journal of …, 2016 - Elsevier
A series of novel di-or trisubstituted isatin derivatives were designed and synthesized in 5–6
steps in 25–45% overall yields. Their structures were confirmed by 1H NMR and 13C NMR …

Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents

MA Yousef, AM Ali, WM El-Sayed, WS Qayed… - Bioorganic …, 2020 - Elsevier
In recent years, cell cycle and checkpoint pathways regulation are offering new therapeutic
approaches against cancer. Isatin, is a well exploited scaffold in the anticancer domain …

Latest advances in cannabinoid receptor agonists

GA Thakur, R Tichkule, S Bajaj… - Expert opinion on …, 2009 - Taylor & Francis
Background: Since the discovery of cannabinoid receptors and their endogenous ligands in
early 1990s, the endocannabinoid system has been shown to play a vital role in several …

Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl) isatin derivatives as anticancer agents

K Han, Y Zhou, F Liu, Q Guo, P Wang, Y Yang… - Bioorganic & Medicinal …, 2014 - Elsevier
Forty four di-or trisubstituted novel isatin derivatives were designed and synthesized in 5–6
steps in 25–45% overall yields. Their structures were confirmed by 1 H NMR and 13 C NMR …